Treatment of refractory stage IV mycosis fungoides with bexarotene monotherapy.
Otremba
Burkhard
B
info@onkopraxis-oldenburg.de
D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000077610:Bexarotene; D006801:Humans; D008297:Male; D009182:Mycosis Fungoides / Q000188:drug therapy* / Q000473:pathology; D009367:Neoplasm Staging; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology; D013764:Tetrahydronaphthalenes / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D013764:Tetrahydronaphthalenes; D000077610:Bexarotene